Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Emerging Challenges in the Management of HIV and Hepatitis C Virus Coinfection in Veterans

Article PDF
Author and Disclosure Information

Phyllis C. Tien, MD

Dr. Tien is a staff physician in the infectious disease section of the San Francisco VA Medical Center and an assistant professor of medicine at the University of California at San Francisco, both in San Francisco, CA. She was the lead author of the VA's recommendations for managing and treating hepatitis C virus infection in HIV-infected adults.

Issue
Federal Practitioner - 25(3)
Publications
Topics
Page Number
12
Legacy Keywords
hepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosinehepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosine
Sections
Author and Disclosure Information

Phyllis C. Tien, MD

Dr. Tien is a staff physician in the infectious disease section of the San Francisco VA Medical Center and an assistant professor of medicine at the University of California at San Francisco, both in San Francisco, CA. She was the lead author of the VA's recommendations for managing and treating hepatitis C virus infection in HIV-infected adults.

Author and Disclosure Information

Phyllis C. Tien, MD

Dr. Tien is a staff physician in the infectious disease section of the San Francisco VA Medical Center and an assistant professor of medicine at the University of California at San Francisco, both in San Francisco, CA. She was the lead author of the VA's recommendations for managing and treating hepatitis C virus infection in HIV-infected adults.

Article PDF
Article PDF

Issue
Federal Practitioner - 25(3)
Issue
Federal Practitioner - 25(3)
Page Number
12
Page Number
12
Publications
Publications
Topics
Article Type
Display Headline
Emerging Challenges in the Management of HIV and Hepatitis C Virus Coinfection in Veterans
Display Headline
Emerging Challenges in the Management of HIV and Hepatitis C Virus Coinfection in Veterans
Legacy Keywords
hepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosinehepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosine
Legacy Keywords
hepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosinehepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosine
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media